![Herbert Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Herbert Cross
Finanzdirektor/CFO bei
JASPER THERAPEUTICS, INC.
Vermögen: - $ am 31.07.2026
Profil
Herbert C.
Cross is currently Director at DNAtrix, Inc. since 2021 and CFO, Secretary & Chief Accounting Officer at Jasper Therapeutics, Inc. since 2023.
Formerly, served as Independent Director at Apexigen, Inc. and Apexigen America, Inc. from 2019 to 2023; Chief Financial Officer at Atreca, Inc. from 2019 to 2023; Chief Financial Officer at Balance Therapeutics, Inc. from 2016 to 2017; Chief Financial & Accounting Officer at ARMO Biosciences, Inc. from 2017 to 2018; Chief Executive & Financial Officer at Humanigen, Inc. in 2015; Chief Financial Officer at Affymax, Inc. from 2011 to 2013; Principal Accounting Officer & Controller at Abbott Biotherapeutics Corp.
from 2008 to 2014; Chief Accounting Officer at PDL BioPharma, Inc. from 2006 to 2009; Vice President-Finance at Neoforma, Inc. from 2001 to 2007; Manager-Assurance & Business Advisory Services at Arthur Andersen LLP in 1999.
Education includes undergraduate degree from Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.08.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Herbert Cross
| Unternehmen | Position | Beginn |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Finanzdirektor/CFO | 22.09.2023 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Direktor/Vorstandsmitglied | 18.02.2021 |
Ehemalige bekannte Positionen von Herbert Cross
| Unternehmen | Position | Ende |
|---|---|---|
| ATRECA, INC. | Finanzdirektor/CFO | 22.09.2023 |
| APEXIGEN, INC. | Direktor/Vorstandsmitglied | 23.08.2023 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Direktor/Vorstandsmitglied | 01.08.2023 |
| ARMO BIOSCIENCES INC | Finanzdirektor/CFO | 21.06.2018 |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disabilities | Finanzdirektor/CFO | 01.11.2017 |
Ausbildung von Herbert Cross
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Provides e-commerce services to healthcare industry | Distribution Services |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disabilities | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
